Eli Lilly and CoChange company Symbol lookupSelect an option...LLY Eli Lilly and CoADN Advent Technologies Holdings IncIMCC IM Cannabis CorpABGI ABG Acquisition I CorpBPT BP Prudhoe Bay Royalty TrustPBT Permian Basin Royalty TrustSUN Sunoco LPBP BP PLCPSX Phillips 66COP ConocophillipsGo
Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Trajenta, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant, Baricitinib, and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups to service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in about 120 countries.
|
|
|
|
| |
Upcoming Events
- FEB
14
2023 - Ex-dividend Date
- Dividend amount
$1.13 - Record date
February 15, 2023 - Pay date
March 10, 2023
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| November 1, 2022 | Q3 2022 Earnings Release | $1.98 | $1.77 to $2.18 | $1.94 |
| August 4, 2022 | Q2 2022 Earnings Release | $1.25 | $1.43 to $1.95 | $1.87 |
| April 28, 2022 | Q1 2022 Earnings Release | $2.62 | $1.95 to $2.66 | $1.87 |
| February 3, 2022 | Q4 2021 Earnings Release | $2.49 | $2.18 to $2.53 | -- |
Past Dividends
| Ex-dividend date | Amount | Record date | Pay date |
|---|---|---|---|
| November 14, 2022 | $0.98 | November 15, 2022 | December 9, 2022 |
| August 12, 2022 | $0.98 | August 15, 2022 | September 9, 2022 |
| May 13, 2022 | $0.98 | May 16, 2022 | June 10, 2022 |
| February 14, 2022 | $0.98 | February 15, 2022 | March 10, 2022 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.